We are live on ! Find out more
NDRA icon

ENDRA Life Sciences

8 hedge funds and large institutions have $707K invested in ENDRA Life Sciences in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

60% more funds holding

Funds holding: 58 (+3)

0% less ownership

Funds ownership: 0%0% (-0%)

14% less capital invested

Capital invested by funds: $824K → $707K (-$117K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
8
Holders Change
+3
Holders Change %
+60%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

NDRA Hedge Fund Activity: Q2 2020 in Review

8 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q2 2020, worth a combined $707K — down 14% from $824K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new NDRA positions and 1 closed out — a net gain of 3 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $29K. The largest seller was ICM Asset Management, cutting an estimated $406K.

  • 8 institutional investors held ENDRA Life Sciences (NDRA) as of Q2 2020, up from 5 in Q1 2020.
  • Funds reported $707K of ENDRA Life Sciences stock for Q2 2020, down 14% quarter-over-quarter.
  • 4 funds opened new ENDRA Life Sciences positions in Q2 2020 and 1 closed out, a net change of +3 holders.
  • The largest ENDRA Life Sciences buyer in Q2 2020 was Citadel Advisors, an estimated $29K added.
  • The largest ENDRA Life Sciences seller in Q2 2020 was ICM Asset Management, an estimated $406K sold.

Based on aggregated 13F filings for Q2 2020.